BlackRock Group’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$25.3M Buy
379,809
+8,939
+2% +$582K 0.01% 740
2016
Q3
$24.6M Buy
370,870
+1,356
+0.4% +$92.7K 0.01% 742
2016
Q2
$26.8M Buy
369,514
+19,944
+6% +$1.37M 0.01% 716
2016
Q1
$22.6M Buy
349,570
+10,776
+3% +$715K 0.01% 753
2015
Q4
$24.3M Buy
338,794
+202,371
+148% +$15M 0.01% 737
2015
Q3
$10.5M Buy
136,423
+76,197
+127% +$6.15M 0.01% 910
2015
Q2
$4.46M Buy
60,226
+8,949
+17% +$644K ﹤0.01% 1177
2015
Q1
$3.72M Sell
51,277
-35,058
-41% -$2.44M ﹤0.01% 1227
2014
Q4
$5.71M Buy
86,335
+46,926
+119% +$2.86M ﹤0.01% 1091
2014
Q3
$2.16M Sell
39,409
-960
-2% -$54.5K ﹤0.01% 1381
2014
Q2
$2.35M Sell
40,369
-32,426
-45% -$1.91M ﹤0.01% 1389
2014
Q1
$4.51M Buy
72,795
+13,832
+23% +$805K ﹤0.01% 1149
2013
Q4
$3.15M Buy
58,963
+2,767
+5% +$148K ﹤0.01% 1248
2013
Q3
$2.82M Buy
56,196
+692
+1% +$33.8K ﹤0.01% 1294
2013
Q2
$2.54M Buy
+55,504
New +$2.48M ﹤0.01% 1193

Other funds holding MD

BlackRock Group's MD Position: Q4 2016 in Review

BlackRock Group increased its Pediatrix Medical (MD) stake by 2.4% in Q4 2016, buying an estimated $582K and bringing the position to 379,809 shares worth $25.3M. The position accounts for 0.01% of the portfolio, ranked #740.

BlackRock Group first reported a position in MD in Q2 2013 and has held it in 15 quarters since. The position peaked at $26.8M in Q2 2016. 383 funds tracked by Wall St. Rank hold MD as of Q4 2016.

  • BlackRock Group held 379,809 shares of Pediatrix Medical worth $25.3M as of Q4 2016.
  • BlackRock Group bought 8,939 Pediatrix Medical shares in Q4 2016, an estimated $582K.
  • Pediatrix Medical made up 0.01% of BlackRock Group's portfolio in Q4 2016, its #740 holding.
  • BlackRock Group first reported a position in Pediatrix Medical in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Group's Pediatrix Medical position peaked at $26.8M in Q2 2016.
  • 383 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.